Samyang KCI Corporation

Samyang KCI Corporation

KKRX:036670
4,810.00
KRW
-35.00
(-0.72%)
799.80EPS
7.63P/E
65.64BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3,105.46
3,576.67
3,543.18
4,062.35
4,513.19
5,641.69
6,473.08
6,810.92
7,576.07
10,187.63
10,214.64
10,237.27
10,853.24
11,007.59
Basic EPS, GAAP
214
302
500
617
370
832
1,061
987
944
1,656
1,022
1,367
905
799.8
Free Cash Flow per Basic Share
125.76
447.71
837.82
-82.73
485.75
488.06
644.8
235.77
147.35
482.14
1,304.99
2,146.14
-256.62
-293.35
Dividend per Share
48.27
76.79
92.19
131.54
180.22
180.35
180.03
200.1
200.05
200.03
249.92
249.93
249.88
- -
Book Value per Share
3,435.7
3,653.22
4,002.2
4,365.62
4,552.23
5,165.52
6,144.93
6,930.85
7,673.89
9,124.94
9,890.79
11,011.6
11,666.09
11,632.99
Tangible Book Value per Share
3,352.47
3,598.49
3,946.81
4,319.49
4,507.83
5,120.61
6,008.78
6,785.78
7,433.57
8,889.43
9,668.89
10,813.79
11,484.52
11,458
Basic Weighted Avg Shares
11
11
11
11
11
11
11
11
11
11
11
11
11
11
Sales/Revenue/Turnover
33,252
39,165
38,680
44,307
48,503
60,588
69,641
73,251
81,501
109,605
109,946
110,185
116,840
118,444
Operating Margin (%)
7.24
8.45
16.61
18.57
10.54
18.81
20.81
19.24
15.27
19.96
9.34
13.63
9.32
7.5
Depreciation Expense
3,037
3,148
2,549
2,044
1,853
1,725
1,856
2,730
3,058
3,783
4,223
4,551
4,367
835
Net Income, GAAP
2,291
3,307
5,458
6,729
3,976
8,935
11,415
10,615
10,155
17,816
11,000
14,713
9,743
8,606
Effective Tax Rate (%)
3.21
9.74
20.1
18.9
20.33
19.83
22.29
21.57
22.99
21.52
17.55
17.11
15.98
12.85
Profit Margin (%)
6.89
8.44
14.11
15.19
8.2
14.75
16.39
14.49
12.46
16.26
10.01
13.35
8.34
7.27
Working Capital
6,275
9,220
14,053
17,010
18,353
28,155
29,148
33,588
38,199
49,679
58,708
73,623
83,222
83,367
LT Debt
3,273
1,070
121
102
82
3,000
31
1,112
1,030
134
169
125
70
57
Total Equity
37,593
40,339
44,167
46,975
48,983
55,582
66,121
74,577
82,573
98,186
106,427
118,487
125,530
125,173
Return on Invested Capital (%)
4.49
5.71
9.72
12.18
7
15.05
16.83
14.68
11.66
17.69
7.81
10.76
7.36
6.21
Return on Capital (%)
5.47
7.11
10.89
12.78
7.18
15.23
17.72
14.5
12.68
19.01
10.46
12.97
7.96
7.02
Return on Common Equity (%)
6.45
8.49
12.92
14.77
8.29
17.09
18.76
15.09
12.92
19.71
10.75
13.08
7.99
7.04

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1,122
234
180
LT Borrowings
- -
- -
- -
LT Finance Leases
89
70
57
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
73,600
69,511
65,637

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
99,080
101,400
103,287
Cash, Cash Equivalents & STI
43,698
40,937
43,368
Accounts Receivable, Net
19,346
19,591
21,035
Inventories
33,768
38,410
36,675
Total Current Liabilities
18,614
18,178
19,920
Payables & Accruals
- -
- -
- -
ST Debt
1,122
234
180
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.11%
11.06%
5.94%
Free Cash Flow
-50.61%
62.61%
-111.96%
Net Income, GAAP
16.07%
6.56%
-33.78%
Sales/Revenue/Turnover
12.14%
10.46%
6.04%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
28,075
31,247
25,579
25,284
110,185
2025
28,299
32,059
28,669
27,812
116,840
2026
29,903
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
294
543
232
298.22
1,367
2025
317
267.87
129.15
191.29
905
2026
211.49
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
249.93
2025
- -
- -
- -
- -
249.88
2026
- -
- -
- -
- -
- -

Company Description

CEO
Jin-Yong Lee
Full Time Employees
204
Sector
Process industries
Industry
Chemicals: major diversified
Address
Seosan-si South Korea
IPO Date
Jan 3, 2001
Website
kciltd.com
Business
Samyang KCI Corporation (KRX: 036670) is a South Korea-based specialty chemicals manufacturer primarily engaged in the development, production, and distribution of high-performance raw materials and functional ingredients for personal care, cosmetics, household goods, and industrial specialty applications. Founded in 1985 and headquartered in Seoul, South Korea, with core manufacturing and research facilities located in the Daesan Petrochemical Complex in Seosan, the company operates as a dedicated specialty chemical subsidiary of Samyang Holdings Corporation within the Samyang Group. The company's primary business activities encompass the synthesis and supply of specialty chemical ingredients categorized into: hair conditioning polymers and natural polymer derivatives, including polyquaternium polymers (Polyquaternium-10, Polyquaternium-7, and Polyquaternium-11) and cationic guar gum derivatives marketed under the Ecopol brand; cationic conditioning surfactants and emulsifiers, including behentrimonium chloride (BTAC), cetrimonium chloride (CTAC), and stearamidopropyl dimethylamine; skin care barrier agents and biomimetic lipid ingredients, including pseudo-ceramides, polyglyceryl-based emulsifiers, and 2-methacryloyloxyethyl phosphorylcholine (MPC) copolymers; antimicrobial boosters and multi-functional preservative blends, including glyceryl caprylate, caprylyl glycol, ethylhexylglycerin, and 1,2-hexanediol formulations; and industrial specialty materials, including optical polymers, acrylic monomers, antistatic agents, and electronic functional additives. Samyang KCI supplies its functional ingredients to global consumer health, beauty, and personal care conglomerates—such as L'Oréal, Unilever, Procter & Gamble, Estée Lauder, Amorepacific, and LG Household & Health Care—exporting across major international markets throughout North America, Europe, the Asia-Pacific region, and Latin America. In recent developments, Samyang KCI has advanced its strategic focus on sustainable, bio-based specialty chemicals by expanding its portfolio of COSMOS- and Ecocert-certified, RSPO-compliant, and natural-origin cosmetic raw materials aligned with international clean beauty regulations. The company has executed operational expansions and upgrades at its Daesan manufacturing facility to increase production capacity for high-purity cationic conditioners, eco-friendly surfactant systems, and next-generation lipid barrier materials. Additionally, Samyang KCI continues to strengthen technical synergies with Samyang Group's bio-chemical platform to develop bio-derived functional polymers, microbiome-friendly cosmetic active agents, and specialty polyol derivatives, while expanding direct sales channels and technical partnerships across key personal care manufacturing hubs in North America, Europe, and Southeast Asia.